Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/sunesis_pharmaceuticals_inc_snss_financial_n_strategic_swot_analysis_review_en.gif)
Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's pipeline products include Vecabrutinib (SNS-062) for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies; SSN-510 for the treatment of hematology and solid tumors. The company partnered programs under development include TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types of cancer. Sunesis is headquartered in South San Francisco, California, the US.
Sunesis Pharmaceuticals Inc Key Recent Developments
Mar 04,2021: Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Nov 16,2020: Sunesis Pharmaceuticals reports third quarter 2020 financial results and recent highlights
Nov 09,2020: Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights
Aug 11,2020: Sunesis Pharmaceuticals reports second quarter 2020 financial results and recent highlights
May 07,2020: Sunesis Pharmaceuticals reports first quarter 2020 financial results and recent highlights
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's pipeline products include Vecabrutinib (SNS-062) for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies; SSN-510 for the treatment of hematology and solid tumors. The company partnered programs under development include TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types of cancer. Sunesis is headquartered in South San Francisco, California, the US.
Sunesis Pharmaceuticals Inc Key Recent Developments
Mar 04,2021: Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Nov 16,2020: Sunesis Pharmaceuticals reports third quarter 2020 financial results and recent highlights
Nov 09,2020: Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights
Aug 11,2020: Sunesis Pharmaceuticals reports second quarter 2020 financial results and recent highlights
May 07,2020: Sunesis Pharmaceuticals reports first quarter 2020 financial results and recent highlights
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Sunesis Pharmaceuticals Inc - Key Facts
Sunesis Pharmaceuticals Inc - Key Employees
Sunesis Pharmaceuticals Inc - Key Employee Biographies
Sunesis Pharmaceuticals Inc - Major Products and Services
Sunesis Pharmaceuticals Inc - History
Sunesis Pharmaceuticals Inc - Company Statement
Sunesis Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sunesis Pharmaceuticals Inc - Business Description
Sunesis Pharmaceuticals Inc - Corporate Strategy
Sunesis Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Sunesis Pharmaceuticals Inc - Strengths
Sunesis Pharmaceuticals Inc - Weaknesses
Sunesis Pharmaceuticals Inc - Opportunities
Sunesis Pharmaceuticals Inc - Threats
Sunesis Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 04, 2021: Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Nov 16, 2020: Sunesis Pharmaceuticals reports third quarter 2020 financial results and recent highlights
Nov 09, 2020: Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights
Aug 11, 2020: Sunesis Pharmaceuticals reports second quarter 2020 financial results and recent highlights
May 07, 2020: Sunesis Pharmaceuticals reports first quarter 2020 financial results and recent highlights
Apr 30, 2020: Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlights
Mar 10, 2020: Sunesis Pharmaceuticals reports fourth quarter and full-year 2019 financial results and recent highlights
Mar 03, 2020: Sunesis Pharmaceuticals to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Sunesis Pharmaceuticals Inc - Key Facts
Sunesis Pharmaceuticals Inc - Key Employees
Sunesis Pharmaceuticals Inc - Key Employee Biographies
Sunesis Pharmaceuticals Inc - Major Products and Services
Sunesis Pharmaceuticals Inc - History
Sunesis Pharmaceuticals Inc - Company Statement
Sunesis Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sunesis Pharmaceuticals Inc - Business Description
Sunesis Pharmaceuticals Inc - Corporate Strategy
Sunesis Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Sunesis Pharmaceuticals Inc - Strengths
Sunesis Pharmaceuticals Inc - Weaknesses
Sunesis Pharmaceuticals Inc - Opportunities
Sunesis Pharmaceuticals Inc - Threats
Sunesis Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 04, 2021: Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Nov 16, 2020: Sunesis Pharmaceuticals reports third quarter 2020 financial results and recent highlights
Nov 09, 2020: Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights
Aug 11, 2020: Sunesis Pharmaceuticals reports second quarter 2020 financial results and recent highlights
May 07, 2020: Sunesis Pharmaceuticals reports first quarter 2020 financial results and recent highlights
Apr 30, 2020: Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlights
Mar 10, 2020: Sunesis Pharmaceuticals reports fourth quarter and full-year 2019 financial results and recent highlights
Mar 03, 2020: Sunesis Pharmaceuticals to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Sunesis Pharmaceuticals Inc, Key Facts
Sunesis Pharmaceuticals Inc, Key Employees
Sunesis Pharmaceuticals Inc, Key Employee Biographies
Sunesis Pharmaceuticals Inc, Major Products and Services
Sunesis Pharmaceuticals Inc, History
Sunesis Pharmaceuticals Inc, Subsidiaries
Sunesis Pharmaceuticals Inc, Key Competitors
Sunesis Pharmaceuticals Inc, Ratios based on current share price
Sunesis Pharmaceuticals Inc, Annual Ratios
Sunesis Pharmaceuticals Inc, Annual Ratios (Cont...1)
Sunesis Pharmaceuticals Inc, Interim Ratios
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Sunesis Pharmaceuticals Inc, Key Facts
Sunesis Pharmaceuticals Inc, Key Employees
Sunesis Pharmaceuticals Inc, Key Employee Biographies
Sunesis Pharmaceuticals Inc, Major Products and Services
Sunesis Pharmaceuticals Inc, History
Sunesis Pharmaceuticals Inc, Subsidiaries
Sunesis Pharmaceuticals Inc, Key Competitors
Sunesis Pharmaceuticals Inc, Ratios based on current share price
Sunesis Pharmaceuticals Inc, Annual Ratios
Sunesis Pharmaceuticals Inc, Annual Ratios (Cont...1)
Sunesis Pharmaceuticals Inc, Interim Ratios
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Sunesis Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Sunesis Pharmaceuticals Inc, Ratio Charts
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Sunesis Pharmaceuticals Inc, Ratio Charts
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021